SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: NeuroInvestment who wrote (1383)10/11/1998 12:43:00 AM
From: Rick Strange  Read Replies (2) | Respond to of 1491
 
N.I. thanks for answering my questions. As you can see the FDA is a bit of an enigma to me.

If at the interim point, statistically significant lower ICP as well as functional outcome benefit were shown, do you think PARS would halt the trial and file for approval? Assuming Phase III pans out, is priority review a given?